Organizations describe decentralized clinical trials (DCTs) in different ways, but each definition shares fundamental characteristics of digital resources and patient-local treatment and monitoring.

Marina Acosta Enslen, Associate Director of the Clinical Management division at Rho, offers her thoughts on DCTs in this issue.

“When I think of a fully decentralized trial, I’m thinking of a completely patient-centric trial where you don’t even really have investigative sites,” she says. “There’s maybe a central site that’s set up to be the coordinating PI, and things like that that are kind of helping with the sponsor and/or CRO who’s involved.”

Read the full article here.